MDMA and magic mushrooms reconsidered for rescheduling by Therapeutic Goods Administration

Alex Crowe
By Alex Crowe
Updated April 18 2021 - 12:42am, first published April 17 2021 - 6:00pm

An application to make MDMA and psilocybin more easily accessible to psychiatrists for mental health treatments will now be independently reviewed following an earlier rejection.

Advertisement

Ad
Alex Crowe

Alex Crowe

Science and Environment Reporter

Alex covers science and environment issues, with a focus on local Canberra stories. alex.crowe@austcommunitymedia.com.au